Alphabet Inc’s Vir Biotechnology VIR Stock Holding History

Alphabet Inc’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,666,666	Closed	-$57.1M	–	25
2020 Q1	$57.1M	Hold	1,666,666	–	–	3.75%	6
2019 Q4	$21M	Buy	+1,666,666	New	+$22.3M	1.27%	11

Other funds holding VIR

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.28B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alphabet Inc's VIR Position: Q2 2020 in Review

Alphabet Inc sold out of Vir Biotechnology (VIR) in Q2 2020, closing a stake of 1,666,666 shares — an estimated $57.1M sold.

Alphabet Inc first reported a position in VIR in Q4 2019 and held it in 2 quarters. The position peaked at $57.1M in Q1 2020. 112 funds tracked by Wall St. Rank hold VIR as of Q2 2020.

Alphabet Inc reported no remaining Vir Biotechnology position as of Q2 2020 after selling out during the quarter.
Alphabet Inc sold 1,666,666 Vir Biotechnology shares in Q2 2020, an estimated $57.1M.
Alphabet Inc first reported a position in Vir Biotechnology in Q4 2019 and held it in 2 quarters.
Alphabet Inc's Vir Biotechnology position peaked at $57.1M in Q1 2020.
112 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2020.

Based on Alphabet Inc's 13F filing for Q2 2020, filed 15 Nov 2022.